the sugar science podcast
Episode 63
Alex Cogdill, PhD
Director of Business Development
and Corporate Strategy at Immunai
Director of Business Development
and Corporate Strategy at Immunai
Alex Cogdill joins us to discuss Immunai, an innovative
biotech company.
Upcoming Events
1.4
MILLION
adults
with T1D
187
THOUSAND
children and adolescents
with T1D under the age of 20
700
MILLION
T1D adults by 2045
$16
BILLION
spent in T1D related
healthcare costs
“The time for scientists working alone is over, collaboration is key”
Ekaterine Bershivili MD, PhDSenior Scientist at University of Geneva
“theSugarScience is doing an awesome job by bridging the gap in a very diverse community of scientists working to better treat/look for a cure for people with type 1 diabetes and by curating valuable content for researchers in the field. Such a valuable tool for us!”.
José García-Tirado, PhdUniversity of Virginia Center for Diabetes Technology
“The ideas that you are discussing as part of The Sugar Science are excellent.”
Matthias Hebrok, PhDUniversity of California San Francisco
“I am a strong supporter of thesugarscience.”
Douglas Melton, PhDHarvard University
Fantastic Idea!
Mark Atkinson, PhDUniversity of Florida
A concept like The Sugar Science will be welcomed.